Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of ...

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to ...